Mario D. Cordero | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Mario D. Cordero | Molecular Biology | Best Researcher Award

Principal Investigator at Pablo de Olavide University, Spain

Mario David Cordero Morales is a distinguished professional and researcher known for his contributions to [specific field/area of expertise]. With a robust academic foundation and a wealth of experience in both academia and industry, he has demonstrated an unwavering commitment to advancing knowledge and fostering innovation. His career is marked by interdisciplinary collaboration, a keen focus on applied research, and significant contributions to [specific applications or innovations]. A recipient of numerous accolades, Mario David is recognized as a leader who consistently bridges the gap between theoretical research and practical implementation.

Professional Profile

Education

Mario David Cordero Morales holds an extensive academic background that has laid the groundwork for his professional success. He earned his [degree] in [field] from [university], where he developed expertise in [key area]. Building on this, he pursued advanced studies, completing a [degree/doctorate] in [specific specialization] at [university], with a thesis focusing on [specific topic]. His educational journey also includes specialized training and certifications in [specific courses], ensuring his alignment with emerging trends and technologies.

Professional Experience

With [X years] of professional experience, Mario David has held pivotal roles in academia, research, and industry. As [current position] at [organization], he leads initiatives in [key responsibilities]. Previously, he contributed significantly as [previous roles] at [institutions/organizations], where he worked on groundbreaking projects like [specific projects]. His professional journey reflects a trajectory of increasing responsibility and influence, with a focus on [core professional themes].

Research Interests

Mario David’s research interests lie at the intersection of [fields], particularly focusing on [specific topics]. His work seeks to address critical challenges in [industry/area], leveraging [specific methodologies or technologies]. He has a strong passion for exploring [emerging topics], which has positioned him as a thought leader in [field]. Through collaboration with global researchers, Mario continues to pioneer advancements in [specific innovations].

Research Skills

Mario David is equipped with a diverse set of research skills that enhance his contributions to [field]. Proficient in [specific methodologies], he excels in [technical skills like data analysis, modeling, lab techniques]. His expertise in [tools/software] enables him to tackle complex research problems efficiently. He is adept at designing and managing large-scale projects, fostering interdisciplinary collaboration, and mentoring junior researchers to achieve excellence.

Awards and Honors

Mario David has received numerous accolades recognizing his excellence in research and professional contributions. Notable honors include [specific awards], which highlight his impact on [field]. He has also been awarded fellowships and grants from esteemed organizations like [specific institutions]. His dedication to [specific cause or innovation] has earned him accolades that underscore his status as a respected figure in [industry/field].

Conclusion

Mario David Cordero Morales is an exemplary researcher with a compelling journey and significant contributions to biomedical research. His work on inflammasomes and aging is both innovative and impactful, supported by an impressive publication record, international collaborations, and leadership in advancing knowledge in this field. While there is scope for diversification and industry engagement, his achievements, resilience, and scientific influence make him a strong contender for the Best Researcher Award.

Publication Top Notes

1.The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Boy-Ruiz, D., Sanz, A., Cordero, M.D.
  • Year: 2024
  • Journal: Aging Cell
  • Volume and Issue: 23(9), e14272

2. Does NLRP1 Inflammasome Activation in Immune Cells in Kidney Transplantation Relate with Donor Organ Age?

  • Authors: Suarez-Rivero, J.M., López-Pérez, J., Astorga-Gamaza, A., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 41(7-9), pp. 479–487

3. NLRP1 inflammasome promotes senescence and senescence-associated secretory phenotype

  • Authors: Muela-Zarzuela, I., Suarez-Rivero, J.M., Gallardo-Orihuela, A., Mbalaviele, G., Cordero, M.D.
  • Year: 2024
  • Journal: Inflammation Research
  • Volume and Issue: 73(8), pp. 1253–1266
  • Citations: 2

4. Does Donor Age Have Effects on Senescence Biomarkers in Kidney-Transplanted Patients?

  • Authors: López-Pérez, J., Suarez-Rivero, J.M., Muela-Zarzuela, I., Mazuecos, A., Cordero, M.D.
  • Year: 2024
  • Journal: Antioxidants and Redox Signaling
  • Volume and Issue: 40(13-15), pp. 751–758
  • Citations: 1

5. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

  • Authors: Castejón-Vega, B., Kyriakidis, N.C., Alcócer-Gómez, E., Cordero, M.D., Alvarez-Suarez, J.M.
  • Year: 2024
  • Journal: Journal of Berry Research
  • Volume and Issue: 14(1), pp. 41–59
  • Citations: 1

6. How the Disruption of Mitochondrial Redox Signalling Contributes to Ageing

  • Authors: Castejon-Vega, B., Cordero, M.D., Sanz, A.
  • Year: 2023
  • Journal: Antioxidants
  • Volume and Issue: 12(4), 831
  • Citations: 8

7. L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation

  • Authors: Castejón-Vega, B., Rubio, A., Pérez-Pulido, A.J., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: Cells
  • Volume and Issue: 10(11), 3122
  • Citations: 3

8. Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria

  • Authors: González-Dominguez, A., Montañez, R., Castejón-Vega, B., Alcocer-Gómez, E., Cordero, M.D.
  • Year: 2021
  • Journal: EMBO Molecular Medicine
  • Volume and Issue: 13(10), e14012
  • Citations: 19

9. Glial cells (Book Chapter)

  • Authors: Williams, M., Macdonald, C., Cordero, M.D.
  • Year: 2021
  • Book: The Neuropathology of Schizophrenia
  • Pages: 221–241

10. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre

  • Authors: Castejón-Vega, B., Battino, M., Quiles, J.L., Cordero, M.D., Bullón, P.
  • Year: 2021
  • Journal: Antioxidants
  • Volume and Issue: 10(1), pp. 1–9, 95
  • Citations: 5

 

 

 

Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Posted on by ScienceFather

Dr. Sukhes Mukherjee | Molecular Biology | Outstanding Scientist Award

Additional Professor at All India Institute Of Medical Sciences Bhopal, India

Dr. Sukhes Mukherjee is a distinguished academic and researcher in the field of biochemistry, with a focus on clinical biochemistry and molecular biology. He currently holds the position of Additional Professor at the All India Institute of Medical Sciences (AIIMS), Bhopal, India. Dr. Mukherjee has built an impressive career over the past 16 years, with substantial contributions to research and education. His work has been widely recognized, earning him numerous awards and honors. He is also known for his leadership in teaching and mentoring students, particularly at the postgraduate level. Dr. Mukherjee’s research focuses on advancing molecular techniques in biochemistry, with an emphasis on health diagnostics and disease management. He has authored over 80 peer-reviewed papers and frequently contributes to conferences and seminars both nationally and internationally.

Professional Profile

Education

Dr. Mukherjee’s educational journey is anchored in biochemistry and molecular biology. He completed his undergraduate and postgraduate education in India, earning a Master’s degree in Medical Biochemistry, followed by a Ph.D. in Biochemistry. His academic training has provided him with a strong foundation in both theoretical knowledge and hands-on laboratory skills. Dr. Mukherjee’s education is complemented by postdoctoral research experiences that have enriched his expertise in clinical biochemistry and molecular diagnostics. He has actively engaged in interdisciplinary training programs and research initiatives, which have shaped his current position as a thought leader in the field.

Professional Experience

Dr. Mukherjee’s professional experience spans more than 16 years, during which he has worked at various prestigious institutions, most notably at AIIMS, Bhopal. In his current role, he is responsible for overseeing clinical biochemistry research, teaching, and administration. Dr. Mukherjee has taught a wide range of courses, from basic biochemistry to advanced molecular biology, guiding both undergraduate and postgraduate students. Additionally, he has served on various academic and research committees, contributing to the development of new curricula and research protocols. His career also includes serving as a mentor to numerous graduate students and postdoctoral researchers, helping them advance their scientific careers.

Research Interests

Dr. Mukherjee’s primary research interests lie in the fields of clinical biochemistry, molecular biology, and health diagnostics. His work focuses on understanding the molecular mechanisms of disease, with particular attention to neurochemistry and biochemical pathways in neurological disorders. He is involved in exploring novel diagnostic biomarkers and therapies to improve patient care. Dr. Mukherjee’s research also covers the application of cutting-edge molecular biology techniques to better understand human health and disease at the cellular and biochemical levels. His interdisciplinary approach includes collaborations with clinicians and other researchers to bridge the gap between benchside research and clinical applications.

Research Skills

Dr. Mukherjee is highly skilled in a range of laboratory techniques and methodologies that are integral to biochemistry and molecular biology. These include protein chemistry, molecular cloning, enzyme assays, and biochemical profiling. He is proficient in various advanced diagnostic techniques, such as mass spectrometry and PCR-based methods, that are essential in clinical research. Dr. Mukherjee also has extensive experience in bioinformatics and data analysis, utilizing computational tools to interpret complex biological data. His research skills are complemented by his ability to manage large-scale research projects and collaborate effectively with multidisciplinary teams.

Awards and Honors

Dr. Mukherjee’s contributions to biochemistry and molecular biology have been recognized through numerous awards and honors. Notably, he received the Best Paper Award from the Association of Clinical Biochemists of India in 2008. He has been a recipient of various travel fellowships to attend and present at international conferences, including those in the US and South Korea. Dr. Mukherjee is a Fellow of the Linnean Society of London, reflecting his international stature in the scientific community. His work continues to attract recognition, both in India and globally, for its impact on advancing clinical biochemistry and molecular diagnostics.

Conclusion

Dr. Sukhes Mukherjee is undoubtedly a highly deserving candidate for the Best Researcher Award, with an impressive record of research contributions, academic excellence, and professional recognition. His extensive research, leadership, and dedication to advancing the field of clinical biochemistry set him apart as a pioneer in his field. With a bit more focus on interdisciplinary research and mentorship, Dr. Mukherjee could have an even more profound influence on both the scientific community and society at large. This nomination reflects his exemplary contributions and positions him as a role model for future researchers in the field.

Publication Top Notes

  1. Alcoholism and its effects on the central nervous system
    Authors: S Mukherjee
    Journal: Current Neurovascular Research 10 (3), 256-262
    Year: 2013
    Citations: 138
  2. Consequences of alcohol consumption on neurotransmitters-an overview
    Authors: S Mukherjee, SK Das, K Vaidyanathan, DM Vasudevan
    Journal: Current Neurovascular Research 5 (4), 266-272
    Year: 2008
    Citations: 86
  3. Evaluation of blood oxidative stress‐related parameters in alcoholic liver disease and non‐alcoholic fatty liver disease
    Authors: SK Das, V Balakrishnan, S Mukherjee, DM Vasudevan
    Journal: Scandinavian Journal of Clinical and Laboratory Investigation 68 (4), 323-334
    Year: 2008
    Citations: 81
  4. Oxidative stress is the primary event: effects of ethanol consumption in brain
    Authors: SK Das, KR Hiran, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 22, 99-104
    Year: 2007
    Citations: 77
  5. Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver
    Authors: SK Das, S Mukherjee, DM Vasudevan, V Balakrishnan
    Journal: Singapore Med J 52 (3), 175-181
    Year: 2011
    Citations: 73
  6. Medicinal properties of milk thistle with special reference to silymarin–an overview
    Authors: SK Das, S Mukherjee, DM Vasudevan
    Publisher: CSIR
    Year: 2008
    Citations: 70
  7. Evolving interplay between dietary polyphenols and gut microbiota—an emerging importance in healthcare
    Authors: SK Ray, S Mukherjee
    Journal: Frontiers in Nutrition 8, 634944
    Year: 2021
    Citations: 68
  8. Biochemical and immunological basis of silymarin effect, a milk thistle (Silybum marianum) against ethanol-induced oxidative damage
    Authors: SK Das, S Mukherjee
    Journal: Toxicology Mechanisms and Methods 22 (5), 409-413
    Year: 2012
    Citations: 63
  9. Protective effect of resveratrol and vitamin E against ethanol-induced oxidative damage in mice: biochemical and immunological basis
    Authors: SK Das, S Mukherjee, G Gupta, DN Rao, DM Vasudevan
    Publisher: CSIR
    Year: 2010
    Citations: 55
  10. Effects of chronic ethanol exposure on renal function tests and oxidative stress in kidney
    Authors: SK Das, S Varadhan, L Dhanya, S Mukherjee, DM Vasudevan
    Journal: Indian Journal of Clinical Biochemistry 23, 341-344
    Year: 2008
    Citations: 49

 

Lian-Wang Guo | Genetics and Molecular Biology| Best Researcher Award

Posted on by ScienceFather

Dr. Lian-Wang Guo | Genetics and Molecular Biology| Best Researcher Award

Professor at University of Virginia, United States

Dr. Lian-Wang Guo is a Professor of Biomedical Sciences at the University of Virginia with over 20 years of experience in vascular biology and biochemistry. His research primarily focuses on the role of epigenetic modulators in vascular diseases, particularly neointima-associated restenosis. He has been continuously funded by the NIH since 2012 and has published 48 peer-reviewed papers in the past six years, while also filing six patent applications. Dr. Guo’s innovative work includes developing biomimetic nanoplatforms for targeted drug delivery, which are currently in advanced trials for treating vascular conditions. His research integrates basic science with clinical applications, notably through collaboration with Dr. Craig Kent. Dr. Guo is recognized for his significant contributions to vascular epigenetics and has created a rigorous and inclusive training environment for young researchers. His work holds promise for advancing therapeutic strategies and improving clinical outcomes for vascular diseases.

Professional Profile

Education

Dr. Lian-Wang Guo’s educational background is rooted in biology and advanced plant physiology, providing a strong foundation for his extensive research career. He earned his Bachelor of Science degree in Biology from Xinjiang University in China in 1989, followed by a Master of Science in Plant Physiology from the prestigious Chinese Academy of Sciences in 1992. He continued his studies there, earning a Ph.D. in Plant Physiology and Biochemistry in 1995. Driven by a passion for genetics and biochemistry, Dr. Guo completed a postdoctoral fellowship at The Hebrew University of Jerusalem in 1998, where he broadened his research expertise in molecular biology. His educational journey reflects a commitment to understanding complex biological processes, which he has successfully applied to his pioneering work in vascular biology and epigenetics. Dr. Guo’s solid academic training has been instrumental in his innovative research contributions and leadership in biomedical sciences.

Professional Experience

Dr. Lian-Wang Guo is a tenured Professor of Biomedical Sciences at the University of Virginia, specializing in vascular biology and epigenetics. With over 20 years of research experience, Dr. Guo has developed an expertise in chromatin modulators and their role in vascular diseases, particularly in neointima-associated restenosis. He has been continuously funded by the NIH since 2012, and his prolific contributions include 48 peer-reviewed publications and multiple patents, reflecting his leadership in vascular epigenetics research. His laboratory employs advanced molecular techniques such as ChIPseq, RNAseq, bioinformatics, and innovative nanoplatforms for targeted drug delivery. Dr. Guo has also successfully fostered clinical collaborations, including the development of therapeutic interventions currently undergoing large animal trials, with preparations for human studies. A dedicated mentor, he has cultivated a rigorous training environment for students and fellows, helping them transition into independent research careers. His research has garnered numerous awards and recognition from prominent scientific organizations.

Research Interests

Lian-Wang Guo’s research interests center around the intersection of vascular biology, epigenetics, and targeted drug delivery. As a professor of Biomedical Sciences, his work focuses on understanding the role of chromatin modulators, such as EZH2, DOT1L, and BRD4, in vascular diseases, particularly neointima-associated restenosis. By uncovering how these epigenetic regulators influence disease-specific gene expression, he aims to develop precise therapeutic strategies that mitigate pathological vascular remodeling while preserving normal cellular functions. Dr. Guo is also deeply involved in translational research, advancing the use of biomimetic nanoplatforms for targeted, localized drug delivery. His lab has developed innovative nanotechnologies to deliver therapeutic agents to disease sites, aiming to enhance efficacy and minimize side effects. A key element of his research is the integration of basic science discoveries with clinical applications, as evidenced by his collaborations on vascular disease treatments currently in advanced stages of preclinical testing.

Lian-Wang Guo, Professor of Biomedical Sciences at the University of Virginia, has earned numerous prestigious awards and honors throughout his distinguished career. In 1996, he received the Award of Excellent Sci/Tech Articles from the Chinese Society of Plant Physiology. He has also been recognized with the University of Wisconsin-Madison Eye Research Institute Rapid Response Initiative Award (2008), the Morgridge Institute for Research Award (2014), and the New Investigator Award from the State of Wisconsin Partnership Program (2014). At The Ohio State University, he earned the Accelerator Award for Translation (2017). His editorial contributions include serving as Lead Guest Editor for Genes and Associate Editor for Frontiers in Cardiovascular Medicine. In 2023, he was elected as a Fellow of the American Heart Association (FAHA), and his outstanding research earned him recognition at the 2023 Research Achievement event at the University of Virginia, marking him as a leading figure in vascular biology and biomedical research.

Dr. Lian-Wang Guo’s extensive research contributions, particularly in vascular biology and epigenetics, position him as a leading scholar in biomedical sciences. His innovative work on chromatin modulators, specifically targeting epigenetic players like BRD4, EZH2, and DOT1L, has brought new insights into the treatment of neointimal-associated vascular diseases. Additionally, his development of nano-based, targeted drug delivery systems has shown promising translational potential, bridging the gap between basic science and clinical applications. With over 20 years of experience, numerous high-impact publications, NIH funding, and significant patents, Dr. Guo’s work is both cutting-edge and impactful. His mentorship of the next generation of scientists, as well as his collaborations with leading clinicians, further enhance his academic profile. While his contributions are already significant, a continued focus on clinical translation could maximize the impact of his research. Overall, Dr. Guo exemplifies the qualities of an outstanding researcher deserving of recognition.

 

Publication top noted
  • Article: Transmembrane protein TMEM97 and epigenetic reader BAHCC1 constitute an axis that supports pro-inflammatory cytokine expression
    Authors: Li, J., Shen, H., Guo, L.-W.
    Year: 2024
    Citations: 0
  • Article: miR579-3p is an inhibitory modulator of neointimal hyperplasia and transcription factors c-MYB and KLF4
    Authors: Xie, X., Shirasu, T., Li, J., Guo, L.-W., Kent, K.C.
    Year: 2023
    Citations: 3
  • Article: Neointima abating and endothelium preserving — An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L
    Authors: Shirasu, T., Yodsanit, N., Li, J., Gong, S., Guo, L.-W.
    Year: 2023
    Citations: 1
  • Article: Targeted PERK inhibition with biomimetic nanoclusters confers preventative and interventional benefits to elastase-induced abdominal aortic aneurysms
    Authors: Yodsanit, N., Shirasu, T., Huang, Y., Gong, S., Wang, B.
    Year: 2023
    Citations: 2
  • Article: Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation
    Authors: Zhang, M., Li, J., Wang, Q., Miller, C.L., Guo, L.-W.
    Year: 2023
    Citations: 3
  • Article: Sphingoid Bases Regulate the Sigma-1 Receptor—Sphingosine and N,N’-Dimethylsphingosine Are Endogenous Agonists
    Authors: Li, J., Satyshur, K.A., Guo, L.-W., Ruoho, A.E.
    Year: 2023
    Citations: 3
  • Article: Retinal Photoreceptor Protection in an AMD-Related Mouse Model by Selective Sigma-1 or Sigma-2 Receptor Modulation
    Authors: Mavlyutov, T.A., Li, J., Liu, X., Pattnaik, B., Guo, L.-W.
    Year: 2022
    Citations: 4
  • Erratum: Correction: miR548ai antagonism attenuates exosome-induced endothelial cell dysfunction (Cell Death Discovery, (2021), 7, 1, (318), 10.1038/s41420-021-00720-9)
    Authors: Xie, X., Guo, L.-W., Kent, C.K.
    Year: 2022
    Citations: 0
  • Article: Differential Responses to Sigma-1 or Sigma-2 Receptor Ablation in Adiposity, Fat Oxidation, and Sexual Dimorphism
    Authors: Li, J., Félix-Soriano, E., Wright, K.R., Stanford, K.I., Guo, L.-W.
    Year: 2022
    Citations: 5
  • Article: SREBP1 regulates Lgals3 activation in response to cholesterol loading
    Authors: Li, J., Shen, H., Owens, G.K., Guo, L.-W.
    Year: 2022
    Citations: 9

Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Posted on by ScienceFather

Dr. Ehsan Saburi | Molecular Biology | Life Sciences Innovation Award

Assistant Professor of Mashhad university of Medical Sciences, Iran.

Dr. Ehsan Saburi is an Assistant Professor at the School of Medicine, Mashhad University of Medical Sciences, specializing in Molecular Medicine. He holds a Ph.D. and has contributed significantly to research in areas such as stem cell therapy, COVID-19, and the molecular mechanisms of various diseases. Dr. Saburi has led numerous research projects, exploring the genetic and molecular aspects of health conditions like COVID-19, cancer, and autoimmune disorders. His work includes the investigation of gene polymorphisms, the therapeutic potential of cell therapy, and the effects of natural compounds on disease progression. Dr. Saburi’s research has been published in high-impact journals, demonstrating his commitment to advancing medical knowledge. His expertise in molecular medicine and his dedication to innovative research make him a strong candidate for the Best Researcher Award.

Profile
Education

Dr. Ehsan Saburi is an accomplished academic with a strong foundation in Molecular Medicine. He earned his Doctor of Philosophy (Ph.D.) in this specialized field, reflecting his deep commitment to advancing medical science. His educational journey is marked by rigorous training and research, equipping him with a profound understanding of molecular mechanisms and their applications in medicine. Dr. Saburi’s academic background is further enriched by his involvement in various research projects at the Mashhad University of Medical Sciences, where he continues to explore the frontiers of medical research. His education has provided him with the skills and knowledge necessary to contribute significantly to the scientific community, particularly in the areas of stem cell research, genetic studies, and the development of innovative medical therapies. Dr. Saburi’s educational achievements underscore his dedication to excellence in both teaching and research, making him a respected figure in his field.

Professional Experience

Dr. Ehsan Saburi is an accomplished Assistant Professor at Mashhad University of Medical Sciences, specializing in Molecular Medicine. With a Ph.D. in the same field, he has played a pivotal role in various research projects, particularly those focusing on the molecular mechanisms of diseases, stem cell therapy, and the impact of genetic polymorphisms on health outcomes. His professional experience is marked by leadership in numerous high-impact studies, including investigations into COVID-19, stem cell differentiation, and the protective effects of natural compounds on organ systems. Dr. Saburi has been instrumental in advancing research in molecular medicine through his extensive work on genetic factors influencing disease severity and innovative therapeutic approaches. His contributions to the academic community are further evidenced by his numerous publications in reputable journals and his active involvement in ongoing research projects aimed at improving health outcomes through molecular and genetic insights.

Research Interest

Dr. Ehsan Saburi’s research interests lie at the intersection of molecular medicine and regenerative medicine, with a particular focus on the therapeutic potential of stem cells and the molecular mechanisms underlying various diseases. His work extensively explores the use of adipose-derived mesenchymal stem cells (AD-hMSCs) in tissue regeneration, particularly in the context of osteogenic and chondrogenic differentiation. Dr. Saburi is also deeply involved in studying the genetic and molecular pathways related to chronic diseases, including cancer and autoimmune disorders. His recent projects have investigated the effects of various bioactive compounds, such as melatonin and curcumin, on mitigating disease symptoms and improving patient outcomes. Additionally, Dr. Saburi’s research includes examining the genetic factors that influence the severity of infectious diseases like COVID-19, aiming to contribute to the development of more effective treatments and vaccines. His multidisciplinary approach positions him at the forefront of translational medicine and therapeutic innovation.

Research Skills

Dr. Ehsan Saburi, an Assistant Professor of Molecular Medicine at Mashhad University of Medical Sciences, demonstrates extensive expertise in advanced molecular and cellular research. His skills encompass a wide range of scientific techniques, including genetic manipulation, stem cell research, and biochemical analysis. Dr. Saburi has led numerous research projects, particularly focusing on the genetic and molecular mechanisms underlying diseases such as cancer, COVID-19, and neurodegenerative disorders. His proficiency in designing and executing complex experiments is evidenced by his successful investigation of various signaling pathways, gene polymorphisms, and therapeutic effects of natural compounds. Additionally, Dr. Saburi is skilled in the use of bioinformatics tools for data analysis and interpretation, contributing to his ability to publish in high-impact journals. His collaborative approach and ability to manage multidisciplinary research teams further highlight his research capabilities, making him a valuable asset in the field of molecular medicine.

Awards and Recognition

Dr. Ehsan Saburi, an accomplished Assistant Professor at Mashhad University of Medical Sciences, has garnered significant recognition for his contributions to molecular medicine. His extensive research on stem cell therapies, COVID-19, and the molecular mechanisms underlying various diseases has earned him numerous accolades. Dr. Saburi’s innovative work on the protective effects of melatonin and curcumin in disease models has been widely acknowledged in the scientific community. He has received several prestigious awards for his groundbreaking research, including the Best Researcher Award from Mashhad University. His publications in high-impact journals and his involvement in pioneering research projects have further solidified his reputation as a leading scientist. Dr. Saburi’s commitment to advancing medical science continues to be recognized through various honors and awards, underscoring his impact on the field and his dedication to improving human health.

Conclusion

Dr. Ehsan Saburi is a highly capable and dedicated researcher with significant contributions to molecular medicine and COVID-19 research. His extensive research activities, leadership in numerous projects, and commitment to advancing medical science make him a strong candidate for the Best Researcher Award. However, to enhance his candidacy further, focusing on the impact of his publications, fostering international collaborations, and pursuing more innovative research avenues would be beneficial.

Publications Top Notes

  1. Title: Advances and challenges of the cell-based therapies among diabetic patients
    Authors: Raoufinia, R., Rahimi, H.R., Saburi, E., Moghbeli, M.
    Journal: Journal of Translational Medicine
    Year: 2024
    Citations: 1
  2. Title: Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies
    Authors: Raoufinia, R., Arabnezhad, A., Keyhanvar, N., Namdar, A.B., Rahimi, H.R.
    Journal: Molecular Biology Reports
    Year: 2024
  3. Title: Hematological changes due to malaria – An update
    Authors: Naser, R.H., Rajaii, T., Farash, B.R.H., Sadabadi, F., Saburi, E.
    Journal: Molecular and Biochemical Parasitology
    Year: 2024
  4. Title: Apoptotic effects of biodentine, calcium-enriched mixture (CEM) cement, ferric sulfate, and mineral trioxide aggregate (MTA) on human mesenchymal stem cells isolated from the human pulp of exfoliated deciduous teeth
    Authors: Nazemi Salman, B., Mohebbi Rad, M., Saburi, E.
    Journal: Minerva Dental and Oral Science
    Year: 2024
  5. Title: Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
    Authors: Raoufinia, R., Rahimi, H.R., Keyhanvar, N., Foroudi, S., Saburi, E.
    Journal: Stem Cell Reviews and Reports
    Year: 2024
    Citations: 1
  6. Title: Role of microRNAs in tumor progression by regulation of kinesin motor proteins
    Authors: Nasimi Shad, A., Fanoodi, A., Maharati, A., Forouzanfar, F., Moghbeli, M.
    Journal: International Journal of Biological Macromolecules
    Year: 2024
  7. Title: Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development
    Authors: Saadh, M.J., Bazghandi, B., Jamialahmdi, H., Esmaeili, S.-A., Saburi, E.
    Journal: European Journal of Pharmacology
    Year: 2024
  8. Title: Synthesis of bone biocompatible implants using human adipose-derived mesenchymal stem cells (hADMSCs) and PCL/laminin scaffold substrate
    Authors: Zeydari, D., Karimi, E., Saburi, E.
    Journal: Iranian Journal of Basic Medical Sciences
    Year: 2024
    Citations: 2
  9. Title: Genetic landscape of hearing loss in prelingual deaf patients of eastern Iran: Insights from exome sequencing analysis
    Authors: Alerasool, M., Eslahi, A., Vona, B., Niknezhad, H.T., Mojarrad, M.
    Journal: Clinical Genetics
    Year: 2024
  10. Title: Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics
    Authors: Raoufinia, R., Rahimi, H.R., Abbaszadeh, M., Khazaei, M., Avan, A.
    Journal: Current Pharmaceutical Design
    Year: 2024

 

Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Hayati Türkmen | Genetics and Molecular Biology | Best Researcher Award 

Turkiye of Ege University, Turkey.

Prof. Dr. Hayati Türkmen is a distinguished academic in the field of inorganic chemistry, specializing in coordination chemistry, metal carbene complexes, catalysis, and boron chemistry. With a solid educational background, including a Ph.D. from Ege University, he has made significant contributions to the field through his extensive research and publications. His research interests span inorganic and organometallic chemistry, health sciences, and novel ligands. Dr. Türkmen has published over 100 papers and has received substantial citations, reflecting his influence in the scientific community. He has held various academic and administrative roles at Ege University, including Vice Dean and Director of Vocational School. His teaching portfolio includes advanced courses in inorganic chemistry and catalysis. Dr. Türkmen’s leadership in research and education, combined with his extensive publications and contributions to the field, highlight his eligibility for the Best Researcher Award.

Profile
Education

Dr. Hayati Türkmen completed his undergraduate studies in Chemistry at Karadeniz Technical University, Turkey, from 1993 to 1997. He then pursued a Master’s degree in Chemistry at Muğla Sıtkı Koçman University, graduating in 2000. Dr. Türkmen continued his academic journey by earning a Doctorate in Chemistry from Ege University, Turkey, between 2000 and 2007. His doctoral research focused on inorganic chemistry, which laid the foundation for his expertise in coordination chemistry, metal carbene complexes, and catalysis. This comprehensive educational background has equipped Dr. Türkmen with a solid foundation in both theoretical and applied chemistry, significantly contributing to his successful academic and research career in the field of inorganic and organometallic chemistry.

Professional Experience

Prof. Dr. Hayati Türkmen has a distinguished career in the field of chemistry, with extensive experience in both academia and administration. He has served as a Professor in the Department of Inorganic Chemistry at Ege University from 2015 to 2022, following his promotion from Associate Professor and Assistant Professor roles within the same department. His academic journey began with a role as a Research Assistant at Muğla Sıtkı Koçman University and Ege University, where he conducted significant research in coordination chemistry and catalysis. Prof. Türkmen has held several key administrative positions, including Vice Dean of the Faculty of Science at Ege University since 2022 and Director of Aliağa Vocational Training School from 2021 to 2022. His leadership extends to roles such as Head of Department at Ege University’s Graduate School of Natural and Applied Sciences and Rectorate Commissioner.

Research Interest

Dr. Hayati Türkmen’s research interests span several key areas within inorganic chemistry, including coordination chemistry, metal carbene complexes, and catalysis. His work focuses on the synthesis and application of novel ligands and metal-organic frameworks, aiming to develop advanced catalysts for industrial and environmental processes. Dr. Türkmen is particularly interested in boron chemistry and organometallic chemistry, exploring the potential of boron-based compounds in various chemical transformations. His research also extends to health sciences, where he investigates the role of metal complexes in biomedical applications. By integrating these diverse fields, Dr. Türkmen strives to advance fundamental understanding and practical applications of inorganic materials. His contributions to the development of new catalytic systems and materials have significant implications for both scientific research and industrial practice, highlighting his commitment to advancing the frontiers of chemistry and materials science.

Research Skills

Prof. Dr. Hayati Türkmen exhibits exceptional research skills across several domains of chemistry. His expertise spans coordination chemistry, metal carbene complexes, catalysis, and boron chemistry, reflecting a strong command over complex chemical systems and reactions. Dr. Türkmen is proficient in the development and application of novel ligands and metal-organic frameworks, which underpin his contributions to both fundamental research and practical applications in inorganic and organometallic chemistry. His research is characterized by meticulous experimental design and rigorous data analysis, as evidenced by his substantial publication record and citation metrics. Dr. Türkmen’s ability to synthesize new compounds and explore their catalytic properties demonstrates his innovative approach to solving chemical problems. His proficiency in mentoring graduate students and leading research projects further highlights his commitment to advancing the field through collaborative and high-impact research initiatives.

 Awards and Recognition

Dr. Hayati Türkmen has garnered significant recognition throughout his distinguished career in chemistry. His contributions to the field have been acknowledged with numerous accolades, reflecting his impact on research and education. Notably, he received the Ege University Research Award in 2021 for his outstanding achievements in inorganic chemistry and catalysis. In 2018, he was honored with the Excellence in Research Award by the Turkish Chemical Society, recognizing his innovative work in metal carbene complexes and boron chemistry. Additionally, Dr. Türkmen’s contributions to academic excellence were celebrated when he was awarded the Faculty Teaching Excellence Award in 2016, highlighting his dedication to education and mentorship. His ongoing influence and leadership in the scientific community are further evidenced by his active role in international research collaborations and editorial boards, cementing his reputation as a leading figure in his field.

Conclusion

Prof. Dr. Hayati Türkmen appears to be a strong candidate for the Research for Best Researcher Award. His extensive research output, significant citations, and leadership roles reflect a high level of accomplishment and influence in his field. Addressing areas for improvement, such as increasing citation impact and focusing research, could further strengthen his application. Overall, his achievements and contributions to science make him a compelling nominee for this prestigious award.

Publications Top Notes

  1. Efficient Synthesis of Novel 1,10 Phenanthroline-Substituted Imidazolium Salts: Exploring Their Anticancer Applications
    • Authors: Çakır, S., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  2. Comparison of Ru(II)‒Arene Complexes Containing Naphthyl-/Quinolinyl-Substituted Ligand Vis-a-Vis Structure, Spectra and Catalytic Activity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Şahin, O., Türkmen, H.
    • Year: 2024
    • Citations: 1
  3. Synthesis of Aryl-Functionalized Benzo[d,e]Benzo[4,5]Imidazo[2,1-a]Isoquinolin-7-One Derivatives: DNA Intercalation Causing Cytotoxicity
    • Authors: Türkmen, G., Çakır, S., Batıkan Kavukcu, S., Türkmen, H.
    • Year: 2024
  4. Synthesis and Characterization of Piano-Stool Ruthenium(II)-Arene Complexes of Isatin Schiff Bases: Cytotoxicity and DNA Intercalation
    • Authors: Karabıyık, H., Karaer Tunçay, A., Ilhan, S., Atmaca, H., Türkmen, H.
    • Year: 2024
  5. Ruthenium Compounds: Are They the Next-Era Anticancer Agents?
    • Authors: Kavukcu, S.B., Özverel, C.S., Kıyak, N., Vatansever, H.S., Türkmen, H.
    • Year: 2024
  6. Anticancer Effect Evaluation of Nitron Complexes
    • Authors: Tolga Özdemir, V., Batıkan Kavukcu, S., Dila Çağlar, A., Nalbantsoy, A., Türkmen, H.
    • Year: 2024
  7. Cell Death Mechanism of Organometallic Ruthenium(II) and Iridium(III) Arene Complexes on HepG2 and Vero Cells
    • Authors: Kavukcu, S.B., Ensarioğlu, H.K., Karabıyık, H., Vatansever, H.S., Türkmen, H.
    • Year: 2023
    • Citations: 3
  8. N-Alkylation and N-Methylation of Amines with Alcohols Catalyzed by Nitrile-Substituted NHC-Ir(III) and NHC-Ru(II) Complexes
    • Authors: Çakır, S., Kavukcu, S.B., Şahin, O., Günnaz, S., Türkmen, H.
    • Year: 2023
    • Citations: 11
  9. Utilization of Various Solid Leather Wastes for the Production of Blended Bricks
    • Authors: Senthil, R., Kavukcu, S.B., Çakır, S., Başaran, B., Alagumuthu, T.
    • Year: 2022
    • Citations: 10
  10. Eco-Friendly Bioenergy: New Approaches for the Effective Treatment of Tannery Fleshings
    • Authors: Rethinam, S., Aruni, A.W., Türkmen, H.
    • Year: 2021
    • Citations: 3

 

Jaafar Abduo | Prosthodontics | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Jaafar Abduo | Prosthodontics | Best Researcher Award

Prosthodontist at Melbourne Dental School, Australia.

Dr. Jaafar Abduo is an Associate Professor of Prosthodontics at Melbourne Dental School, University of Melbourne. He holds a PhD from the University of Western Australia and has extensive experience in clinical dentistry. His research focuses on digital workflows, implant prosthodontics, and the evaluation of modern dental manufacturing techniques. Dr. Abduo has published over 90 peer-reviewed papers and has a significant impact on the field, with an h-index of 30 and more than 4,600 citations. He collaborates with leading dental companies and has been awarded multiple national and international grants. Additionally, he serves on various academic and professional committees, contributing to research ethics, curriculum development, and continuing education. Dr. Abduo’s work has been presented at major international conferences, and his innovations have influenced both academic research and clinical practices in prosthodontics globally.

Profile
Education

Dr. Jaafar Abduo’s educational background is distinguished by his extensive training in dentistry and prosthodontics. He earned his Doctor of Philosophy (PhD) by publication from the University of Western Australia in 2016, which reflects his significant contributions to dental research. Prior to this, he completed the Doctor of Clinical Dentistry in Prosthodontics (DClinDent) at the University of Otago, Dunedin, New Zealand, in 2010, underscoring his specialized expertise in prosthodontics. His journey began with a Bachelor of Dental Surgery with credit from the University of Otago in 2004. Additionally, he achieved Membership of the Royal Australasian College of Dental Surgeons in Prosthodontics (MRACDS Pros) through examination in Sydney, Australia, in 2011. This robust educational foundation has equipped Dr. Abduo with the knowledge and skills necessary to advance the field of dental prosthetics.

Professional Experience

Dr. Jaafar Abduo is an accomplished prosthodontist and Associate Professor at the Melbourne Dental School, University of Melbourne. Since January 2020, he has held the position of Associate Professor (Level D) in Prosthodontics, where he also serves as the Convenor for the Doctor of Clinical Dentistry (Prosthodontics) program and the Postgraduate Diploma in Clinical Dentistry (Implants). Dr. Abduo’s career at the Melbourne Dental School began in 2013 as a Senior Lecturer (Level C) in Prosthodontics. Alongside his academic roles, he has been a practicing specialist prosthodontist in private practice since 2011. Dr. Abduo’s expertise spans removable prosthodontics, complex rehabilitation, and implant prosthodontics, and he is actively involved in both teaching and research. His work is well-regarded, with numerous peer-reviewed publications and significant contributions to advancing dental education and clinical practice.

Research Interest

Dr. Jaafar Abduo’s research interests are centered around advancing prosthodontics, with a particular focus on digital dentistry and modern manufacturing techniques. He explores the development and evaluation of digital workflows for diagnostics, conventional, removable, and implant prosthodontics, aiming to improve accuracy and efficiency in dental treatments. His work also includes randomized controlled trials to assess the clinical outcomes of materials such as monolithic zirconia and metal-ceramic implant crowns. Additionally, Dr. Abduo is interested in optimizing digital scanning methods for natural teeth, soft tissue, and implants. His biomechanical studies on implant and natural tooth comparisons, along with his research on the durability of dental prosthetics, contribute to enhancing the quality and longevity of dental restorations. Through his research, Dr. Abduo seeks to bridge the gap between clinical practice and technological advancements, ultimately improving patient outcomes in prosthodontics.

Research Skills

Dr. Jaafar Abduo possesses a comprehensive set of research skills that have greatly contributed to the field of prosthodontics. His expertise lies in digital dentistry, particularly in developing and optimizing digital workflows for various prosthodontic procedures, including implant and removable prosthodontics. He is proficient in conducting randomized controlled trials and biomechanical evaluations, ensuring the clinical efficacy and durability of dental materials and techniques. Dr. Abduo’s collaboration with industry leaders showcases his ability to bridge academic research with practical applications, enhancing dental treatment outcomes. His supervisory experience, guiding numerous Doctor of Clinical Dentistry and postgraduate students, demonstrates his mentorship skills and commitment to advancing dental education. Additionally, Dr. Abduo has secured multiple research grants, highlighting his capability in securing funding and managing large-scale projects. His strong publication record, with a high h-index and numerous citations, underscores his ability to disseminate research findings effectively and contribute to the broader scientific community.

Awards and Recognition

Dr. Abduo has received several prestigious awards and grants, including the F. A. Kernott Early Career Researcher Award and various grants from the Australian Dental Research Foundation and international sources. His high h-index and citation count further demonstrate his impact and recognition in the field.

Conclusion

Dr. Jaafar Abduo is a highly deserving candidate for the Research for Best Researcher Award. His extensive research contributions, collaborative efforts, and impactful projects in prosthodontics reflect his dedication to advancing dental science. His work has both national and international significance, making him a prominent figure in the field of dental research.

Publications Top Notes

  • “Muscle and joint mechanics during maximum force biting following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2024
    • Citations: 0
  • “Effect of prefabricated immediate interim prosthesis design and insertion workflow on seating accuracy on implants placed via static computer-assisted implant surgery: A cross-sectional in vitro study”
    • Authors: Abduo, J., Lau, D.
    • Year: 2024
    • Citations: 0
  • “Influence of Implant Adjacent Teeth on the Accuracy of Digital Impression”
    • Authors: Abduo, J., El-Haddad, H.
    • Year: 2024
    • Citations: 0
  • “Seating accuracy of removable partial denture frameworks fabricated by different digital workflows in comparison to conventional workflow”
    • Authors: Korkes, A., Jomaa, J., Kavouris, A., Law, K.H.J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “Effect of pilot-guided implant placement concept on the accuracy of osteotomy preparation and implant placement”
    • Authors: Sharma, S., Tan, E., Tran, B., Teo, J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “The Effect of Various Lasers on the Bond Strength Between Orthodontic Brackets and Dental Ceramics: A Systematic Review and Meta-Analysis”
    • Authors: Mosaddad, S.A., Abduo, J., Zakizade, M., Tebyaniyan, H., Hussain, A.
    • Year: 2024
    • Citations: 2
  • “Accuracy of Static Computer-Assisted Implant Placement in Posterior Edentulous Areas with Different Levels of Tooth-Support by Novice Clinicians”
    • Authors: Abduo, J., Lau, D.
    • Year: 2023
    • Citations: 0
  • “Kinematics of the jaw following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2023
    • Citations: 3
  • “Marginal Accuracy of Monolithic and Veneered Zirconia Crowns Fabricated by Conventional and Digital Workflows”
    • Authors: Abduo, J., Ho, G., Centorame, A., Le, P., Ngo, C.
    • Year: 2023
    • Citations: 3
  • “Measuring tooth movement with treatment using the Dahl principle: An observational study”
    • Authors: Bhai, K., Judge, R., Abduo, J., Palamara, J.
    • Year: 2023
    • Citations: 1

Mariela Gironacci | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Mariela Gironacci | Molecular Biology | Best Researcher Award

Professor at University of Buenos Aires , Argentina.

Dr. Mariela Mercedes Gironacci is a distinguished Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University. With a Ph.D. from the University of Buenos Aires and a career spanning over two decades, Dr. Gironacci has made significant contributions to hypertension research. Her work focuses on the Mas receptor and its role in anti-inflammatory and antihypertensive responses. She has led multiple research projects funded by CONICET and other national and international bodies. Dr. Gironacci has received numerous awards, including the Braun Menéndez Award and the Prof. Dr. Luis Moledo Award, recognizing her excellence in hypertension research. She is an active member of professional societies, serves on editorial boards, and has delivered invited lectures globally. Her research impact is evident in her extensive publications and her leadership in advancing our understanding of the renin-angiotensin system.

Profile
Education

Dr. Mariela Mercedes Gironacci holds a distinguished educational background in the field of pharmacology and biochemistry. She earned her Bachelor’s degree in Pharmacy from the National University of Córdoba, Argentina, in 1988. Building upon this foundation, she pursued advanced studies at the University of Buenos Aires, where she completed her Ph.D. in 1999. Her doctoral research contributed significantly to the understanding of the renin-angiotensin system, particularly in relation to hypertension. Dr. Gironacci’s academic journey reflects a strong commitment to advancing knowledge in her field, laying the groundwork for her subsequent research and professional achievements. Her education has equipped her with the expertise necessary to make substantial contributions to pharmacology and biochemistry, particularly in hypertension and cardiovascular research.

Professional Experience

Dr. Mariela Mercedes Gironacci is an esteemed Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University, where she has served since March 2023. Her academic career began as an Instructor in 1991, progressing to Assistant Professor (1996-2008) and then Associate Professor (2008-2023) before her current role. Concurrently, Dr. Gironacci has been a Principal Investigator at the National Council of Scientific and Technical Research (CONICET) since December 2019. Her research focuses on hypertension and cardiovascular health, particularly the Mas receptor’s role in antihypertensive responses. Her leadership extends to serving on various editorial boards, including Hypertension and the Journal of the Argentinian Society of Hypertension, and she has held significant positions in professional societies, including the Inter-American Society of Hypertension. Her extensive experience in teaching, research, and leadership underscores her significant contributions to the field.

Research Interest

Dr. Mariela Mercedes Gironacci’s research primarily focuses on the role of the renin-angiotensin system (RAS) in cardiovascular health, particularly through the study of angiotensin-(1-7) and its associated Mas receptor. Her work delves into the antihypertensive and cardioprotective properties of angiotensin-(1-7), exploring its interactions with other receptors and its impact on conditions such as hypertension and Alzheimer’s disease. Dr. Gironacci’s research also examines the receptor’s involvement in inflammatory responses and its potential therapeutic targets for hypertension and neurodegenerative disorders. She is engaged in elucidating the mechanisms behind Mas receptor trafficking and its role in regulating blood pressure and cardiac function. Her contributions extend to investigating the biological responses triggered by receptor interactions, aiming to advance the understanding and treatment of hypertension and related cardiovascular diseases.

Research Skills

Dr. Mariela Mercedes Gironacci demonstrates exceptional research skills through her extensive work on the Mas receptor and its role in cardiovascular health. Her expertise encompasses a deep understanding of receptor regulation and trafficking, particularly in relation to antihypertensive responses. Dr. Gironacci has led pioneering studies on the depressor axis of the renin-angiotensin system, focusing on the receptor Mas and its interactions with other receptors. Her ability to design and execute complex research projects is evident in her numerous high-impact publications and successful grant applications. She employs advanced methodologies including receptor heteromerization studies, FRET approaches, and molecular modeling to unravel the mechanisms underlying hypertension and cardiovascular diseases. Additionally, her role as an editor and reviewer for leading journals underscores her commitment to maintaining rigorous research standards and advancing the field of cardiovascular pharmacology.

Awards and Recognition

Dr. Gironacci has received numerous awards for her contributions to hypertension research, including prestigious recognitions such as the Braun Menendez Award, the Luis Moledo Award, and the Prof. Dr. C. Taquini Award. These accolades reflect her excellence in research and her impact on the field. Her recognition extends to both national and international levels, highlighting her standing as a leading researcher in her field.

Conclusion

Dr. Mariela Mercedes Gironacci’s extensive research contributions, impactful projects, and numerous awards position her as a strong candidate for the Best Researcher Award. Her work has advanced scientific understanding of hypertension and related conditions, with significant implications for both clinical practice and public health. Her dedication to research, collaborative efforts, and recognition by prestigious institutions underscore her outstanding achievements in the field.

Publications Top Notes

  1. Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension
    • Authors: J. Minetto, M.B. Cuello, F.P. Dominici, W.G. Espeche, M.M. Gironacci
    • Year: 2024
  2. Unraveling the crosstalk between renin-angiotensin system receptors
    • Authors: M.M. Gironacci, E. Bruna-Haupt
    • Year: 2024
  3. Valproate decreases transgenerationally blood pressure by affecting thyrotropin-releasing hormone promoter DNA methylation and gene expression in spontaneously hypertensive rat
    • Authors: M.S. Landa, M.L. Schuman, M. Aisicovich, S.I. García, C.J. Pirola
    • Year: 2024
  4. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli
    • Authors: C. Berdasco, A. Pinto, M.G. Blake, J. Gironacci, J. Goldstein
    • Year: 2023
    • Citations: 1
  5. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, M. Nuñez, M.M. Gironacci
    • Year: 2023
    • Citations: 12
  6. Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D
    • Authors: M.G. Silva, F. Inserra, J. Mariani, W. Manucha, M.M. Gironacci
    • Year: 2023
    • Citations: 1
  7. Mas receptor endocytosis and signaling in health and disease
    • Authors: N.L. Rukavina Mikusic, M.M. Gironacci
    • Year: 2023
  8. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19
    • Authors: M.G. Silva, G.R. Corradi, J.I. Pérez Duhalde, W.G. Espeche, M.M. Gironacci
    • Year: 2022
    • Citations: 6
  9. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, G.R. Guman, M.M. Gironacci
    • Year: 2022
    • Citations: 4
  10. ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors
    • Authors: A.E. Portales, E.R. Mustafá, C.I. McCarthy, M. Perelló, J. Raingo
    • Year: 2022
    • Citations: 8